Middle East and Africa Cell Therapy Bioprocessing Market to Grow at a CAGR of 11.3% to reach US$ 832.5 Million Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Cell Therapy Bioprocessing Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Cell Therapy Bioprocessing Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Cell therapy approvals growing
5.1.3 Chronic diseases and cancer driving demand
5.1.4 Gene-editing and stem cell technologies advancing
5.1.5

5.2 Market Opportunities

5.2.1
5.2.2 Growing adoption of automated bioprocessing systems for scalable and efficient cell production.
5.2.3 Expansion into emerging markets with improving healthcare infrastructure and biomanufacturing capabilities.
5.2.4 Rising collaborations between biotech companies and research institutions for novel therapy development.

5.3 Future Trends

5.3.1
5.3.2 Development of closed-system bioprocessing for enhanced safety and contamination control.
5.3.3 Growth in personalized cell therapies requiring flexible and small-scale bioprocessing solutions.
5.3.4 Increasing integration of AI and machine learning for optimized cell therapy production and quality control.

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Cell Therapy Bioprocessing Market Regional Analysis

6.1 Middle East and Africa Cell Therapy Bioprocessing Market Overview

6.2 Middle East and Africa Cell Therapy Bioprocessing Market Revenue 2019-2028 (US$ Million)

6.3 Middle East and Africa Cell Therapy Bioprocessing Market Forecast Analysis

7. Middle East and Africa Cell Therapy Bioprocessing Market Analysis – by Technology

7.1 Bioreactor

7.1.1 Overview
7.1.2 Bioreactor: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Lyophilization

7.2.1 Overview
7.2.2 Lyophilization: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Electrospinning

7.3.1 Overview
7.3.2 Electrospinning: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Control flow Centrifugation

7.4.1 Overview
7.4.2 Control flow Centrifugation: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Ultrasonic Lysis

7.5.1 Overview
7.5.2 Ultrasonic Lysis: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Genome Editing Technology

7.6.1 Overview
7.6.2 Genome Editing Technology: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Cell Immortalization Technology

7.7.1 Overview
7.7.2 Cell Immortalization Technology: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Viral Vector Technology

7.8.1 Overview
7.8.2 Viral Vector Technology: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Cell Therapy Bioprocessing Market Analysis – by Cell Type

8.1 Stem Cell

8.1.1 Overview
8.1.2 Stem Cell: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Immune Cell

8.2.1 Overview
8.2.2 Immune Cell: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Human Embryonic Stem Cell

8.3.1 Overview
8.3.2 Human Embryonic Stem Cell: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Pluripotent Stem Cell

8.4.1 Overview
8.4.2 Pluripotent Stem Cell: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hematopoietic Stem Cells

8.5.1 Overview
8.5.2 Hematopoietic Stem Cells: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Cell Therapy Bioprocessing Market Analysis – by Indication

9.1 Cardiovascular Disease

9.1.1 Overview
9.1.2 Hematopoietic Stem Cells: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Oncology

9.2.1 Overview
9.2.2 Hematopoietic Stem Cells: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Wound Healing

9.3.1 Overview
9.3.2 Hematopoietic Stem Cells: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Orthopaedic

9.4.1 Overview
9.4.2 Hematopoietic Stem Cells: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Cell Therapy Bioprocessing Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Technology
10.1.1.1.2 South Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Cell Type
10.1.1.1.3 South Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Indication

10.1.1.2 Saudi Arabia: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Technology
10.1.1.2.2 Saudi Arabia: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Cell Type
10.1.1.2.3 Saudi Arabia: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Indication

10.1.1.3 UAE: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Technology
10.1.1.3.2 UAE: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Cell Type
10.1.1.3.3 UAE: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Indication

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Cell Therapy Bioprocessing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Technology
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Cell Type
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Cell Therapy Bioprocessing Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Cell Therapy Bioprocessing Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Fresenius Kabi Ag.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Asahi Kasei Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Sartorius Ag

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Merck Kgaa

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Thermo Fisher Scientific Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Corning Incorporated

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Cytiva (Ge Healthcare)

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Lonza

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Repligen

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Catalent Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights